DOES OXIDATIVE STRESS PARTICIPATE IN NERVE-CELL DEATH IN PARKINSONS-DISEASE

被引:103
作者
HIRSCH, EC
机构
[1] INSERM U-289, Hôpital de la Salpêtrière, Paris
关键词
CELL DEATH; PARKINSONS DISEASE; FREE RADICALS; SUBSTANTIA-NIGRA; CALCIUM;
D O I
10.1159/000118538
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is characterized by a massive neuronal loss in several cell groups of the midbrain. However, the most consistent lesions are observed in dopaminergic systems including nigral neurons. Although the cause of this neuronal loss remains unknown, oxidative stress has been suspected to participate in the mechanism of nerve cell death for several reasons. (1) Lipid peroxidation, a consequence of oxygen free radical production, has been found to be elevated in the substantia nigra in Parkinson's disease. (2) Catecholaminergic neurons containing neuromelanin, an autooxidation by-product of catecholamines, are more vulnerable in Parkinson's disease than non-melanized catecholaminergic neurons. (3) Catecholaminergic neurons surrounded by a low density of cells containing glutathione peroxidase, a free radical scavenging enzyme, are more susceptible to degeneration in Parkinson's disease than those well protected against oxidative stress. (4) The content of iron, a compound which exacerbates the production of free radicals in catecholaminergic neurons, is increased in the substantia nigra in Parkinson's disease. It remains, however, to be determined whether oxidative stress participates to the cause of the disease or only represents a consequence of nerve cell death.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 63 条
[1]   BRAIN PEROXIDASE AND CATALASE IN PARKINSON DISEASE [J].
AMBANI, LM ;
VANWOERT, MH ;
MURPHY, S .
ARCHIVES OF NEUROLOGY, 1975, 32 (02) :114-118
[2]   LOSS OF NEURONS IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE, PARALYSIS AGITANS AND KORSAKOFFS DISEASE [J].
ARENDT, T ;
BIGL, V ;
ARENDT, A ;
TENNSTEDT, A .
ACTA NEUROPATHOLOGICA, 1983, 61 (02) :101-108
[3]   EXPRESSION OF ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS IN THE SUBSTANTIA-NIGRA OF RAT, MONKEY, AND HUMAN [J].
BEAN, AJ ;
ELDE, R ;
CAO, YH ;
OELLIG, C ;
TAMMINGA, C ;
GOLDSTEIN, M ;
PETTERSSON, RF ;
HOKFELT, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10237-10241
[4]   PARKINSONS-DISEASE AND DEMENTIA - NOREPINEPHRINE AND DOPAMINE IN LOCUS-CERULEUS [J].
CASH, R ;
DENNIS, T ;
LHEUREUX, R ;
RAISMAN, R ;
JAVOYAGID, F ;
SCATTON, B .
NEUROLOGY, 1987, 37 (01) :42-46
[5]  
CASPER D, 1990, Society for Neuroscience Abstracts, V16, P999
[6]  
CASPER D, 1989, Society for Neuroscience Abstracts, V15, P708
[7]   SUPEROXIDE-DISMUTASE AND PARKINSONS-DISEASE [J].
CEBALLOS, I ;
LAFON, M ;
JAVOYAGID, F ;
HIRSCH, E ;
NICOLE, A ;
SINET, PM ;
AGID, Y .
LANCET, 1990, 335 (8696) :1035-1036
[8]   ACIDIC FIBROBLAST GROWTH-FACTOR STIMULATES ADRENAL CHROMAFFIN CELLS TO PROLIFERATE AND TO EXTEND NEURITES, BUT IS NOT A LONG-TERM SURVIVAL FACTOR [J].
CLAUDE, P ;
PARADA, IM ;
GORDON, KA ;
DAMORE, PA ;
WAGNER, JA .
NEURON, 1988, 1 (09) :783-790
[9]   CHARACTERIZATION OF THE BINDING OF N-METHYL-4-PHENYLPYRIDINE, THE TOXIC METABOLITE OF THE PARKINSONIAN NEUROTOXIN N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE, TO NEUROMELANIN [J].
DAMATO, RJ ;
BENHAM, DF ;
SNYDER, SH .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (02) :653-658
[10]   GLUTATHIONE-PEROXIDASE, GLIAL-CELLS AND PARKINSONS-DISEASE [J].
DAMIER, P ;
HIRSCH, EC ;
ZHANG, P ;
AGID, Y ;
JAVOYAGID, F .
NEUROSCIENCE, 1993, 52 (01) :1-6